Niagen Bioscience Inc Statistics Share Statistics Niagen Bioscience Inc has 79.75M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 79.75M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares 20 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 3.49M, so 4.43% of the outstanding
shares have been sold short.
Short Interest 3.49M Short % of Shares Out 4.43% Short % of Float 6.75% Short Ratio (days to cover) 3.23
Valuation Ratios The PE ratio is 53.05 and the forward
PE ratio is 39.
Niagen Bioscience Inc's PEG ratio is
-0.22.
PE Ratio 53.05 Forward PE 39 PS Ratio 4.55 Forward PS 5.2 PB Ratio 9.84 P/FCF Ratio 37.97 PEG Ratio -0.22
Financial Ratio History Enterprise Valuation Niagen Bioscience Inc has an Enterprise Value (EV) of 411.74M.
EV / Sales 4.13 EV / EBITDA 44.71 EV / EBIT 34 EV / FCF 34.47
Financial Position The company has a current ratio of 3.57,
with a Debt / Equity ratio of 0.06.
Current Ratio 3.57 Quick Ratio 3.06 Debt / Equity 0.06 Debt / EBITDA 0.29 Debt / FCF 0.22 Interest Coverage 0
Financial Efficiency Return on Equity is 18.55% and Return on Invested Capital is 14.53%.
Return on Equity 18.55% Return on Assets 12.52% Return on Invested Capital 14.53% Revenue Per Employee $957.66K Profits Per Employee $82.21K Employee Count 104 Asset Turnover 1.46 Inventory Turnover 4.14
Taxes Income Tax 305K Effective Tax Rate 3.44%
Stock Price Statistics The stock price has increased by 247.87% in the
last 52 weeks. The beta is 2.12, so Niagen Bioscience Inc's
price volatility has been higher than the market average.
Beta 2.12 52-Week Price Change 247.87% 50-Day Moving Average 11.67 200-Day Moving Average 7.93 Relative Strength Index (RSI) 43.29 Average Volume (20 Days) 1,127,129
Income Statement In the last 12 months, Niagen Bioscience Inc had revenue of 99.6M
and earned 8.55M
in profits. Earnings per share was 0.1.
Revenue 99.6M Gross Profit 61.59M Operating Income 7.73M Net Income 8.55M EBITDA 9.21M EBIT 7.73M Earnings Per Share (EPS) 0.1
Full Income Statement Balance Sheet The company has 44.51M in cash and 2.65M in
debt, giving a net cash position of 41.86M.
Cash & Cash Equivalents 44.51M Total Debt 2.65M Net Cash 41.86M Retained Earnings -181.91M Total Assets 81.34M Working Capital 55.38M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 12.11M
and capital expenditures -163K, giving a free cash flow of 11.95M.
Operating Cash Flow 12.11M Capital Expenditures -163K Free Cash Flow 11.95M FCF Per Share 0.14
Full Cash Flow Statement Margins Gross margin is 61.84%, with operating and profit margins of 7.76% and 8.58%.
Gross Margin 61.84% Operating Margin 7.76% Pretax Margin 8.89% Profit Margin 8.58% EBITDA Margin 9.25% EBIT Margin 7.76% FCF Margin 11.99%
Dividends & Yields NAGE does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 1.88% FCF Yield 2.63%
Dividend Details Analyst Forecast The average price target for NAGE is $16,
which is 63.1% higher than the current price. The consensus rating is "Strong Buy".
Price Target $16 Price Target Difference 63.1% Analyst Consensus Strong Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number 1.1 Graham Upside -88.79%
Stock Splits The last stock split was on Apr 13, 2016. It was a
backward
split with a ratio of 1:3.
Last Split Date Apr 13, 2016 Split Type backward Split Ratio 1:3
Scores Altman Z-Score 17.55 Piotroski F-Score 7
